Fusix Biotech GmbH

Let's celebrate what we do best: partnerships. Join me at BIO-Europe, November 4–6, 2024, in Stockholm, Sweden, where the event marks 30 years of facilitating partnerships. Register here: https://lnkd.in/dxP2XNGk Informa Connect

🎉 This year, Frontiers Health is proud to strengthen its collaboration with EIT Health to drive health innovation and foster collaboration across Europe. EIT Health’s enhanced participation at #FH24 includes several impactful sessions:    🔸EIT Health Start-Up Growth will curate the session 𝐁𝐞𝐲𝐨𝐧𝐝 𝐠𝐫𝐚𝐧𝐭 𝐟𝐮𝐧𝐝𝐢𝐧𝐠: 𝐓𝐡𝐞 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐜𝐞 𝐨𝐟 𝐩𝐮𝐛𝐥𝐢𝐜 𝐟𝐮𝐧𝐝𝐢𝐧𝐠 𝐢𝐧 𝐚 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐢𝐧𝐠 𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭 [𝐌𝐚𝐬𝐭𝐞𝐫𝐜𝐥𝐚𝐬𝐬] exploring how grant funding can complement private funding and provide additional support during challenging times. EIT Health-supported start-ups will share their firsthand experiences, offering valuable insights. https://lnkd.in/dK3XHKnM Aline Noizet Santiago Brandi John Klepper Elizabeth McGloughlin Luis Valente Todor Jeliaskov  🔸 EIT Health Germany-Switzerland will host the session  𝐋𝐞𝐬𝐬𝐨𝐧𝐬 𝐋𝐞𝐚𝐫𝐧𝐞𝐝 𝐨𝐧 𝐒𝐮𝐩𝐩𝐨𝐫𝐭𝐢𝐧𝐠 𝐄𝐧𝐭𝐫𝐞𝐩𝐫𝐞𝐧𝐞𝐮𝐫𝐬𝐡𝐢𝐩: 𝐀 𝐃𝐢𝐯𝐞 𝐢𝐧𝐭𝐨 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐒𝐭𝐚𝐫𝐭𝐮𝐩 𝐂𝐚𝐬𝐞𝐬 https://lnkd.in/d5EnZuYT and the 𝐂𝐚𝐭𝐚𝐩𝐮𝐥𝐭 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐒𝐞𝐥𝐞𝐜𝐭𝐢𝐨𝐧 𝐏𝐢𝐭𝐜𝐡 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐨𝐧, where finalist start-ups from the German and Swiss regions will pitch their innovative solutions and receive expert feedback from a panel of experts. https://lnkd.in/e32W-4qA Jiskia Reis Nino Bellengé Kurt Höller Yasemin Sezer Roberto Iannone Fernando Benito Abad Kerstin von Diemar Lorenz Wiegand Daniela Schumacher Jennifer Altomonte Martin Wegner, Dr. Dipl.-Bioinf. Petra Burgstaller Susie A. Ruff Nicolas Stalder Dr. Fei Tian    🔸 EIT Health InnoStars will lead the dedicated deep dive session 𝐇𝐨𝐰 𝐄𝐈𝐓 𝐇𝐞𝐚𝐥𝐭𝐡 𝐈𝐧𝐧𝐨𝐒𝐭𝐚𝐫𝐬 𝐃𝐫𝐢𝐯𝐞𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐄𝐔: 𝐀 𝐂𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧 𝐰𝐢𝐭𝐡 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬 𝐨𝐧 𝐁𝐞𝐬𝐭 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞𝐬 𝐚𝐧𝐝 𝐍𝐞𝐰 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬. [𝐃𝐞𝐞𝐩 𝐃𝐢𝐯𝐞], highlighting their collaborative initiatives across Italy, Hungary, Poland, and Portugal. This session will provide key insights into InnoStars' network, future plans, and opportunities for partnership. Additionally, InnoStars will take part in the FH24 Innovation Ecosystem Gathering, engaging with Europe's top players to discuss the future of health innovation. Chiara Maiorino Luiza Almeida, MBA Reka Kovacs Monika Ślęzak Daniela Terracciano   Meet the EIT Health Team at FH24, register here: https://lnkd.in/dmdSEa3Q

Fusix Biotech is an early-stage university spinout based in Munich, Germany. They are developing a completely novel, synthetic oncolytic virus platform that offers potent tumor cell killing via a unique mechanism of action, modulatory activity in the tumor microenvironment and induction of systemic anti-tumor immunity, and optimal gene delivery in an all-in-one therapeutic approach that is delivered intravenously for solid tumors. Their pipeline of """"armed"""" vectors are effective as standalone therapies or as components in combinatorial immunotherapy approaches. Fusix is currently raising a Seed financing round in order to bring its lead development candidate to IND-readiness. They are interested in meeting relevant potential investors and strategic partners. Meet Fusix Biotech GmbH @ #Sachs_BEF More Info @ https://lnkd.in/d7zEuKym #BigPharma #Dealmakers #PharmaIndustry #BiotechInEuropeForum #LifeSciences #Biotech #BioPharma #Partnering #Investment #Startups #Oncology #Neurology #Genomics #Immunotherapy #CNS #Autoimmune #Cardiovascular #BiotechIndustry #BioTechInvestment #Innovation #InvestmentForum #BiotechConference #EuropeanBiotech #SachsAutumnLifeSciencesWeek #SALSW

We are excited to continue our partnership with Nucleate in 2024 to unlock the potential of science founders at the earliest stages across university campuses. https://lnkd.in/eCYGEWmY

🏆 𝗖𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗶𝗻𝗴 𝗦𝘂𝗰𝗰𝗲𝘀𝘀: 𝗠𝗲𝗿𝗰𝗸 𝗔𝗱𝘃𝗮𝗻𝗰𝗲 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗚𝗿𝗮𝗻𝘁 𝗘𝘃𝗲𝗻𝘁 𝗮 𝗥𝗲𝘀𝗼𝘂𝗻𝗱𝗶𝗻𝗴 𝗛𝗶𝘁 𝗮𝗺𝗼𝗻𝗴 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗦𝘁𝗮𝗿𝘁𝘂𝗽𝘀❗ 🎉 We're thrilled to announce the 𝗠𝗲𝗿𝗰𝗸 𝗔𝗱𝘃𝗮𝗻𝗰𝗲 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗚𝗿𝗮𝗻𝘁 winners amongst the highly competent attendees at the German Entrepreneurship Center. 𝗧𝗼𝗽 𝗛𝗼𝗻𝗼𝗿𝘀:  🥇 Fusix Biotech GmbH Biotech led by Dr. Jennifer Altomonte took home the first price, showcasing groundbreaking work that captivated everyone present. 🥈 The second place was clinched by Invitris under the direction of Dr. Patrick Grossmann, PhD, MBA, impressing us with their innovative approaches. 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗘𝘃𝗲𝗻𝗶𝗻𝗴: 🌟 The biotech community witnessed firsthand the disruptive innovations poised to shape the future of healthcare. 🌟 Attendees networked with elite biotech professionals, sparking collaborations that will fuel the industry's growth. 🌟 The event affirmed Munich's standing as a nexus for biotech excellence, with both winners exemplifying the pioneering spirit Merck champions. 🙌 A hearty thank you and congratulations to the Merck team Ann-Kathrin Uebele, Ulrike Schneckenburger, Ljubomir Grozdev, Christian Uhrich, Sladjana Tomic-Skrbic for sparking so much energy and passion among all the attendees and winners. Here's to many more years of innovation and success in the biotech industry! 🔗 Merck Gruppe Merck Life Science #GermanEntrepreneurship #MerckBiotechGrant #Innovation #BiotechRevolution #BiotechSuccess #biotechnology #therapreutics #geneandcelltherapy #immunooncology #antibodies